Pharma & Biotech

A high-stakes patent dispute with pharmaceutical titan Merck has emerged as the dominant factor influencing Halozyme Therapeutics' stock trajectory. While...

Laboratory of America Holdings (Labcorp) finds itself at the center of a tug-of-war between bullish and bearish analysts this week....

The shares of biopharmaceutical firm Akebia Therapeutics are navigating a period of significant volatility. While a minor stabilization has emerged...

Organogenesis Holdings Inc. (ORGO) experienced a notable single-day gain of 3.06% during yesterday's trading session, closing at $4.72 per share....

Lexicon Pharmaceuticals faces a significant postponement in its regulatory timeline for Zynquista. The U.S. Food and Drug Administration (FDA) has...

Thermo Fisher Scientific finds itself at a curious crossroads, presenting investors with a mix of confident internal projections and external...

Conflicting corporate developments have placed Ocugen shares on a volatile path, torn between a significant strategic setback and a promising...

Moderna Inc. has achieved a significant manufacturing milestone, resulting in a notable uptick for its shares. The mRNA specialist announced...

Lantheus Holdings finds itself at the center of a significant legal challenge as a series of class-action lawsuits allege the...

Rhythm Pharmaceuticals finds itself at a pivotal moment, caught between promising analyst projections and a recent downtrend in its share...